Eosinophilic esophagitis (EoE) is a chronic (long-term) condition affecting the esophagus, the tube that carries food and liquids from the mouth to the stomach. EoE causes symptoms like difficulty ...

Benralizumab is an eosinophil-depleting anti–interleukin-5 receptor α monoclonal antibody. The efficacy and safety of benralizumab in patients with eosinophilic esophagitis are unclear. In a phase 3, ...

Etrasimod, a once-daily oral selective sphingosine-1-phosphate receptor modulator, is well tolerated and effective in treating eosinophilic esophagitis (EoE), demonstrating sustained histologic and ...

The risk of venous and arterial thrombosis in polycythemia vera patients with secondary malignancies. Temporal trends in myeloproliferative neoplasms–related mortality in the United States over the ...